Neuroone Medical Stock Target Price and Analyst Consensus
| NMTC Stock | USD 0.76 0.02 2.70% |
The current analyst and expert consensus on Neuroone Medical is Strong Sell, with no strong buy opinions. The current projected Neuroone Medical target price consensus is 2.10 with 0 analyst opinions. Check out Macroaxis Advice on Neuroone Medical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Neuroone Medical Tec analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Neuroone Medical executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Neuroone Medical. We encourage you to use your own analysis of Neuroone Medical Tec to validate this buy or sell advice. Neuroone Medical buy-or-sell recommendation module provides average expert sentiment on the projected Neuroone Medical Tec target price to derive its highest and lowest estimates based on projected price volatility of 5.663.
Lowest Forecast 1.91 | Highest Forecast 2.33 | Target Price 2.1 |
Neuroone |
It's important to approach Neuroone Medical's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Neuroone Medical price targets
Neuroone Medical's stock target price is an estimate of its future price, usually made by analysts. Using Neuroone Medical's target price to determine if it is a suitable investment can be done through the following steps:- Look at Neuroone Medical's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Neuroone Medical's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Neuroone Medical Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Neuroone Medical is a key component of Neuroone Medical valuation and have some predictive power on the future returns of a Neuroone Medical.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuroone Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested over 40 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Business Services Invested few shares | |
 | Investor Favorites Invested over 40 shares | |
 | Impulse Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Investing Invested few shares | |
 | Semiconductor Invested few shares | |
Check out Macroaxis Advice on Neuroone Medical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Please note, the presentation of Neuroone Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Neuroone Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Neuroone Medical's management manipulating its earnings.